KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : Min Hwan Kim

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 8건 중 1-8 번을 표시중입니다.

1 Article Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16) Se Hyun Kim ; Seock-Ah Im ; Koung Jin Suh ; et al 2023
2 Article Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer Min Hwan Kim ; Gun Min Kim ; Jin Mo Ahn ; et al 2023
3 Article Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor-Positive Metastatic Breast Cancer Seul-Gi Kim ; Min Hwan Kim ; Sejung Park ; et al 2023
4 Article Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer Kyoungmin Lee ; Jongwon Lee ; Jungmin Choi ; et al 2023
5 Article Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA Mingyun Bae ; Gyuhee Kim ; Tae-Rim Lee ; et al 2023
6 Article Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial Masato Takahashi ; Javier Cortés ; Rebecca Dent ; et al 2023
7 Article Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B) Sung Hoon Sim ; Jeong Eun Kim ; Min Hwan Kim ; et al 2022
8 Article Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer Hee Kyung Ahn ; Sung Hoon Sim ; Koung Jin Suh ; et al 2022

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.